Summary
Two cannabis medicines have been approved to treat multiple sclerosis and epilepsy, but critics argue that the government's embrace of medical marijuana has been far too slow.
Article Preview
One year after the United Kingdom legalized medical marijuana, health officials have approved two cannabis-based medicines designed to help treat multiple sclerosis and rare forms of epilepsy.
This week, the National Institute for Health and Care Excellence (NICE) approved Epidyolex, a CBD-based oral solution, to treat Lennox-Gastaut syndrome and Dravet syndrome, two rare forms of epilepsy. In clinical trials, this medicine has been shown to reduce the number of seizures by up to...
Read the full article @ Merry Jane